Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Biology|May 25, 2002
Xenopus LSm proteins bind U8 snoRNA via an internal evolutionarily conserved octamer sequenceNenad Tomasevic, Brenda A Peculis
Molecular Cell|April 1, 2004
Xenopus U8 snoRNA binding protein is a conserved nuclear decapping enzymeTrina Ghosh, Brian Peterson, Nenad Tomasevic, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2007
Src phosphorylation of cortactin enhances actin assemblyShandiz Tehrani, Nenad Tomasevic, Scott Weed, et al.
Biochemistry|February 17, 2007
Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2Nenad Tomasevic, Zhiheng Jia, Alan Russell, et al.
JCI Insight|August 30, 2019
Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritisBradford A Youngblood, Emily C Brock, John Leung, et al.
Molecular Biology of the Cell|April 11, 2008
R-Spondin family members regulate the Wnt pathway by a common mechanismKyung-Ah Kim, Marie Wagle, Karolyn Tran, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2016
Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxisPaul J Bryce, Rustom Falahati, Laurie L Kenney, et al.
International Archives of Allergy and Immunology|August 12, 2019
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in MiceBradford A Youngblood, Emily C Brock, John Leung, et al.
Growth Factors (Chur, Switzerland)|November 22, 2014
A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activityNenad Tomasevic, Kenneth Luehrsen, Mark Baer, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2014
The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disordersFanny Legrand, Nenad Tomasevic, Olga Simakova, et al.
Pageof 2